Matches in Wikidata for { <http://www.wikidata.org/entity/Q58581045> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q58581045 description "article scientifique publié en 2018" @default.
- Q58581045 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q58581045 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58581045 description "scientific article published on 23 October 2018" @default.
- Q58581045 description "wetenschappelijk artikel" @default.
- Q58581045 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q58581045 name "Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23]" @default.
- Q58581045 name "Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151" @default.
- Q58581045 type Item @default.
- Q58581045 label "Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23]" @default.
- Q58581045 label "Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151" @default.
- Q58581045 prefLabel "Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23]" @default.
- Q58581045 prefLabel "Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151" @default.
- Q58581045 P1433 Q58581045-D10990B5-AD8C-4B68-B5F8-A23734DE6A0C @default.
- Q58581045 P1476 Q58581045-29FB748A-79CE-4244-9465-0C6BC1BFA0B5 @default.
- Q58581045 P2093 Q58581045-1EF29284-466F-4D69-86B8-91A95B2B8F32 @default.
- Q58581045 P2093 Q58581045-2347D2C1-ABFD-478B-A319-3FB8537B9D9A @default.
- Q58581045 P2093 Q58581045-34A8C259-0312-4174-ADAA-A5E393A0F3FE @default.
- Q58581045 P2093 Q58581045-5FBFD918-D37C-43A3-BB7C-C8C01321E7F1 @default.
- Q58581045 P2093 Q58581045-671EF2C1-7352-4F17-A110-4AF99274C7C0 @default.
- Q58581045 P2093 Q58581045-7B6893A1-5885-4B89-8F2C-49A90EB54E89 @default.
- Q58581045 P2093 Q58581045-8106EB9E-4635-433F-8FF3-4BE5162A0B1F @default.
- Q58581045 P2093 Q58581045-9D92F678-03AC-4D62-9756-17C90C306A57 @default.
- Q58581045 P2093 Q58581045-AEB22398-328A-4BDB-9816-80B78FF1272E @default.
- Q58581045 P2093 Q58581045-AEF97CC4-318A-4C3B-AE56-0BC5FE6F5E4E @default.
- Q58581045 P2093 Q58581045-DC86D874-D406-4436-BD29-834F522FBBBD @default.
- Q58581045 P2093 Q58581045-E7D487C4-DDF3-46ED-8CC8-652A9F379193 @default.
- Q58581045 P2093 Q58581045-EF64C4D8-BA3C-41F0-8680-2BC0FE8ECB40 @default.
- Q58581045 P304 Q58581045-4D5A5074-10B2-4C7C-B913-3AED00797C8A @default.
- Q58581045 P31 Q58581045-615DF32E-FE03-4DB4-AA0A-C32E41F45448 @default.
- Q58581045 P31 Q58581045-9EA14CF4-983E-4B96-AC67-E00C525FFC28 @default.
- Q58581045 P356 Q58581045-6A773D9A-88C9-45D1-8A8C-8992C1D7F380 @default.
- Q58581045 P407 Q58581045-312572AF-8ADA-492E-ACDB-0940E44CD4A0 @default.
- Q58581045 P433 Q58581045-0EDA32F5-8379-4964-9490-9A56173B9D56 @default.
- Q58581045 P478 Q58581045-BB936813-64EF-4EE0-A6DC-E171B54C9EC3 @default.
- Q58581045 P577 Q58581045-47CA4540-03D6-4A46-8CEE-1ADE25BEAA26 @default.
- Q58581045 P698 Q58581045-0619A41C-349E-4B02-8413-46A3B6027849 @default.
- Q58581045 P921 Q58581045-16DB8CCB-8892-41F3-8F6B-BFC49482F109 @default.
- Q58581045 P921 Q58581045-59B1DC04-138D-48B3-9B97-CA69259E013B @default.
- Q58581045 P932 Q58581045-C39B60E0-5086-4888-A2A4-D77F1023CECE @default.
- Q58581045 P356 J.YGYNO.2018.10.022 @default.
- Q58581045 P698 30360899 @default.
- Q58581045 P1433 Q5625182 @default.
- Q58581045 P1476 "Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23]" @default.
- Q58581045 P2093 "Alexander B Olawaiye" @default.
- Q58581045 P2093 "David G Mutch" @default.
- Q58581045 P2093 "David M O'Malley" @default.
- Q58581045 P2093 "Diane C Bodurka" @default.
- Q58581045 P2093 "Gretchen Glaser" @default.
- Q58581045 P2093 "James J Java" @default.
- Q58581045 P2093 "Melissa Geller" @default.
- Q58581045 P2093 "Michael A Bookman" @default.
- Q58581045 P2093 "Michael Friedlander" @default.
- Q58581045 P2093 "Robert M Wenham" @default.
- Q58581045 P2093 "Roger B Lee" @default.
- Q58581045 P2093 "Thomas C Krivak" @default.
- Q58581045 P2093 "Thomas J Herzog" @default.
- Q58581045 P304 "220" @default.
- Q58581045 P31 Q13442814 @default.
- Q58581045 P31 Q1348305 @default.
- Q58581045 P356 "10.1016/J.YGYNO.2018.10.022" @default.
- Q58581045 P407 Q1860 @default.
- Q58581045 P433 "1" @default.
- Q58581045 P478 "152" @default.
- Q58581045 P577 "2018-10-23T00:00:00Z" @default.
- Q58581045 P698 "30360899" @default.
- Q58581045 P921 Q172341 @default.
- Q58581045 P921 Q974135 @default.
- Q58581045 P932 "6321790" @default.